Replies to post #240393 on Elite Pharmaceuticals Inc (ELTP)

[rocioyogi]

Dah, why wouldn't Pfizer launch sooner or later and whoever buys Elite will make the money later but that will be built into the buyout price

[WeeZuhl]

Instead of waiting them out...

Pfizer hasn't saved Elite anything yet. If Pfizer doesn't launch then on this assumption means Elite needs to spend $30-70 million more. Lovely.

We should smoke them out. Pfizer's Troxyca was an NDA using Roxicodone and Revia as RLD's, exactly like SequestOx. If Pfizer can use an IR oxy as RLD for ER oxy then why cannot we do the exact same? This avoids their 3 year FDA exclusivity and the Paragraph IV notification. Whatever the cost to develop ELI-201, I would think it is all pretty much paid for by now. Rounding out the HAL studies or whatever else is needed to complete the app will be negligible.


Nasrat! Pay attention! Screw Pfizer. File ELI-201 NOW with Roxi & Revia as RLD, just like Troxyca did.